FSV vs HR

FSV demonstrates exceptional fundamental health with a Piotroski F-Score of 8/9, signaling strong operational efficiency and financial stability. However, the stock is trading at a significant premium, with a current price of $145.74 far exceeding both its Graham Number ($46.33) and Intrinsic Value ($93.52). While earnings growth is robust at 19.5% and analysts maintain a bullish target of $207, the technical trend is severely bearish (0/100) with a 20.5% decline over the last six months. The investment case currently rests on a conflict between high-quality internal health and an overextended valuation in a downward price trend.

Healthcare Realty Trust (HR) presents a precarious fundamental profile, anchored by a stable but mediocre Piotroski F-Score of 4/9 and a complete lack of positive net earnings. While the stock has seen a 1-year price recovery of 25%, this is decoupled from operational reality: revenue is declining (-7.8% YoY) and the dividend payout ratio is an unsustainable 251.53%. The combination of negative profit margins and poor liquidity ratios suggests the current valuation is speculative rather than value-driven.